Sage Journals: Discover world-class research

Retricted access

Research article

First published 2009-02

Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

G Giovannoni, O Barbarash, F Casset-Semanaz [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 1995-09

Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study

G Comi, F Barkhof, L Durelli [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Neutralizing antibodies in MS therapy: reviewing the Rebif experience

A. AL-Sabbagh

Multiple Sclerosis Journal

Retricted access

Case report

First published 2016-10

Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis

Tamara Strohm, Burhan Chaudhry, Mary A Willis [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2004-12

The Expression of Microfilament-Associated Cell-Cell Contacts in Brain Endothelial Cells Is Modified by IFN-β1a (Rebif ® )

Michael Harzheim, Manuela Stepien-Mering, Rolf Schröder [...]

Journal of Interferon & Cytokine Research

Free access

Letter

First published 2002-9

Depression in Multiple Sclerosis Associated with Interferon Beta-1a (Rebif)

Rupang Pandya, Scott Patten

The Canadian Journal of Psychiatry

Retricted access

Research article

First published 2003-02

IFN- β 1a (Rebif ® ) Modifies the Expression of Microfilament-Associated Cell-Cell Contacts in C6 Glioma Cells

Michael Harzheim, Manuela Altenschmidt, Michael T. Heneka [...]

Journal of Interferon & Cytokine Research

Retricted access

Brief report

First published 2002-12

Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN- β Preparations Used in the Treatment of Relapsing-Remitting Multiple Sclerosis

Francesco Antonetti, Ornella Finocchiaro, Michele Mascia [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2005-10

A randomized,multicentre,open-label,parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis

D Mikol, M Lopez-Bresnahan, S Taraskiewicz [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-11

Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

C. Boz, J. Oger, E. Gibbs [...]

Multiple Sclerosis Journal

Search results